Demand For Atopic Dermatitis Market Is Poised To Surpass A Valuation Of US$ 19 Bn By The End Of The Forecast Period 2022-2032

Atopic Dermatitis

Dermatological disorders are highly prevalent in various forms across the globe. According to the World Health Organization, more than 900 million people were affected by skin diseases in 2017. Out of these diseases, atopic dermatitis affects more than 300 million people globally.

Around one-fifth of the victims include children. This increased incidence of this disease is expected to leverage the growth of the atopic dermatitis market in the foreseeable future.

Click Here To get a Sample Report :-

Global Atopic Dermatitis Drugs Market Segmentation

Fact.MR has studied the global atopic dermatitis drugs market with detailed segmentation on the basis product type, application and key regions.

  • By Drug Class :

    • Corticosteroids
    • PDE4 Inhibitors
    • Biologics
    • Skin Barrier Emollients
    • CNI Immunosuppressants
    • Others
  • By Distribution Channel :

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Key Regions :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Product Development to Remain Growth Lever for Market Players

The global atopic dermatitis drugs market is dominated by six key players. These are

  • Mylan M.V.
  • Pfizer Inc.
  • LEO Pharma A/S
  • Teva Pharmaceutical Industries Ltd
  • Sanofi
  • Novartis AG.